In the present study the expression of AGO2, SSB, and NF2 is downregulated in early-stage cancer and upregulated in advance-stage cancer; whereas PPARA was overexpressed and DICER1 was inhibited across all stages of prostate cancer (Fig 3B). The gene discussed is AGO2; the disease is prostate carcinoma.